INTERNATIONAL PATENT: APROFOL AG FILES APPLICATION FOR "FOLATE FOR USE IN METHODS OF REDUCING SEVERITY, INCIDENCE OR RISK IN LYMPHEDEMA OR IN GLYMPHATIC- RELATED NEURODEVELOPMENTAL DISORDERS"

GENEVA, Jan. 26 -- APROFOL AG (Brulisauerstrasse 189050 Appenzell Steinegg) filed a patent application (PCT/EP2025/070269) for "FOLATE FOR USE IN METHODS OF REDUCING SEVERITY, INCIDENCE OR RISK IN LYMPHEDEMA OR IN GLYMPHATIC- RELATED NEURODEVELOPMENTAL DISORDERS" on Jul 16, 2025. With publication no. WO/2026/017709, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AYOUB, George (128 E.Canon PerididoSanta Barbara, California 93103)

Abstract: A composition is described comprising at least one folate which is useful in the t...